Related Experiment Video
Updated: Mar 17, 2026

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
Status dystonicus in children: Early recognition and treatment prevent serious complications
Laura Combe1, Ishaq Abu-Arafeh1
1Department of Paediatrics, Forth Valley Royal Hospital, Larbert, FK5 4WR, UK.
Insights
Status dystonicus (SD) in children with cerebral palsy can be successfully treated with early recognition and supportive care. Prompt intervention prevents serious complications, leading to full recovery within days.
Area of Science:
- Neurology
- Paediatrics
Background:
- Status dystonicus (SD) is a severe complication in children with dyskinetic cerebral palsy.
- Prompt diagnosis and management are crucial for favorable outcomes.
Observation:
- A retrospective study analyzed four episodes of SD in three children (11-15 years) with severe dyskinetic cerebral palsy.
- Infections triggered SD in three of the four episodes.
- Early symptoms included muscle spasms, dysphagia, poor sleep, distress, and pain.
Findings:
- Patients received supportive treatment, rehydration, benzodiazepines, baclofen, and L-dopa.
- No patients required intensive care.
- All patients recovered fully within 5-14 days.
Implications:
- Early recognition and treatment of SD are vital for preventing severe complications in children with cerebral palsy.
- This study highlights the effectiveness of a multidisciplinary approach to managing SD.
Abstract:
This is a retrospective study of all patients presenting to our paediatric unit with status dystonicus (SD) over a period of five years. Anonymous information was collected and a descriptive analysis is made. There were four episodes of SD in three children between 11 and 15 years of age. All children are known to have severe dyskinetic cerebral palsy and presented with an acute or sub-acute deterioration in their symptoms. Symptoms were triggered by infections in three of the four episodes. Early features included frequent and repetitive generalized muscle spasms, poor swallowing, poor sleep, distress and pain. Patients responded to supportive treatment, rehydration, benzodiazepines, baclofen and l-dopa. Intensive care was not necessary in any of the patients and patients made full recovery within 5-14 days. This report shows the value of early recognition and treatment of SD can be successful in preventing serious complications.
More Related Videos
07:20Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
Published on: August 9, 2024
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Related Concept Videos
Depolarizing Blockers: Pharmocokinetics
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Skeletal Muscle Relaxants: Therapeutic Uses
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...